Advertisement

Topics

Pfizer Declares 32-Cent Third-Quarter 2017 Dividend

16:05 EDT 22 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
The board of directors of Pfizer Inc. today declared a 32-cent third-quarter 2017 dividend on the company’s common stock, payable September 1, 2017, to shareholders of record at the close of business on August 4, 2017. The thi...

Other Sources for this Article

Pfizer Inc.
Media:
Joan Campion, 212-733-2798
or
Investors:
Ryan Crowe, 212-733-8160

NEXT ARTICLE

More From BioPortfolio on "Pfizer Declares 32-Cent Third-Quarter 2017 Dividend"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...